Health ❯Reproductive Health ❯Abortion ❯Medication Abortion

Mifepristone

FDA Launches Mifepristone Safety Review, Weighing How the Drug Is Dispensed

No changes to access have been announced as the agency evaluates real-world evidence.

FDA Confirms Safety Review of Mifepristone With No Regulatory Changes Yet

Louisiana Issues Arrest Warrant for California Doctor Accused of Mailing Abortion Pills

HHS and FDA Open Review of Mifepristone’s Safety and Dispensing